Journal of Cardiothoracic and Vascular Anesthesia
Volume 21, Issue 2 , Pages 208-211 , April 2007

Cardiopulmonary Bypass for Lung Transplantation in Cystic Fibrosis: Pilot Evaluation of Perioperative Outcome

  • Alberto Pochettino, MD

      Affiliations

    • Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
    • ,
  • John G.T. Augoustides, MD, FASE

      Affiliations

    • Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationAddress reprint requests to John G.T. Augoustides, MD, FASE, Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, 680 Dulles, 3400 Spruce Street, Philadelphia, PA 19104-4283.
    • ,
  • Deborah A. Kowalchuk, BA

      Affiliations

    • Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA
    • ,
  • Sam M. Watcha, BA

      Affiliations

    • Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA
    • ,
  • Doreen Cowie, CCP

      Affiliations

    • Department of Clinical Perfusion, Hospital of the University of Pennsylvania, Philadelphia, PA.
    • ,
  • David R. Jobes, MD

      Affiliations

    • Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA

References 

  1. Egan TM, Detterbeck FC, Mill MR, et al. Lung transplantation for cystic fibrosis: Effective and durable therapy in a high-risk group. Ann Thorac Surg. 1998;66:337–346
  2. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report 2006. J Heart Lung Transplant. 2006;25:880–892
  3. Kaiser LR, Pasque MK, Trulock EP, et al. Bilateral sequential lung transplantation: The procedure of choice for double-lung replacement. Ann Thorac Surg. 1991;52:438–446
  4. Kirklin JK, Westaby S, Blackstone EH. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845–857
  5. McRae K. Con: Lung transplantation should not be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:746–750
  6. Wang Y, Kurichi JE, Blumenthal NP, et al. Multiple variables affecting blood usage in lung transplantation. J Heart Lung Transplant. 2006;25:533–538
  7. Dalibon N, Geffroy A, Moutafis M, et al. Use of cardiopulmonary bypass for lung transplantation: A 10-year experience. J Cardiothorac Vasc Anesth. 2006;20:668–672
  8. Lell WA, Reynolds HJ, McGiffin DC, et al. The effect of cardiopulmonary bypass in patients undergoing bilateral lung transplantation. Anesthesiology. 2006;105:A596;(abstr)
  9. Vricella LA, Karamichalis JM, Ahmad S. Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: The Stanford experience. Ann Thorac Surg. 2002;74:13–18
  10. Tsiotou AG, Sakorafas GH, Anagnostopoulos G, et al. Septic shock—Current pathogenetic concepts from a clinical perspective. Med Sci Monit. 2005;11:76–85
  11. Christie JD, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–1459
  12. Christie JD, Sager JS, Kimmel SE, et al. Impact of primary graft failure on outcomes following lung transplantation. Chest. 2005;127:161–165
  13. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  14. Yamashita H, Akamine S, Sumida Y, et al. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. Ann Thorac Surg. 2004;78:292–297
  15. Cornfield DN, Milla CE, Haddad IY, et al. Safety of inhaled nitric oxide after lung transplantation. J Heart Lung Transplant. 2003;22:903–907
  16. Okada Y, Marchevsky AM, Kass RM, et al. A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation. Transplantation. 1998;66:1132–1136
  17. Wendel HP, Heller W, Gallimore MJ, et al. The prolonged activated clotting time with aprotinin depends on the type of activator used for measurement. Blood Coagul Fibrinolysis. 1993;4:41–45
  18. Szeto WY, Kreisel D, Karakousis GC, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg. 2002;124:241–249
  19. Mendeloff EN. Lung transplantation for cystic fibrosis. Semin Thorac Cardiovasc Surg. 1998;10:202–212
  20. Egan TM, Detterbeck FC, Mill MR, et al. Lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg. 2002;22:602–609
  21. Coloni GF, Venuta F, Ciccone AM, et al. Lung transplantation for cystic fibrosis. Transplant Proc. 2004;36:648–650
  22. Mathias MA, Tribble CG, Dietz JF, et al. Aprotinin improves pulmonary function during reperfusion in an isolated lung model. Ann Thorac Surg. 2000;70:1671–1674
  23. Shimoyama T, Tabuchi N, Kojuna K, et al. Aprotinin attenuated ischemia-reperfusion injury in an isolated rat model after 18 hours preservation. Eur J Cardiothorac Surg. 2005;28:581–587
  24. Bittner HB, Richter M, Kuntze T, et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg. 2006;29:210–215

PII: S1053-0770(06)00363-6

doi: 10.1053/j.jvca.2006.09.001

Journal of Cardiothoracic and Vascular Anesthesia
Volume 21, Issue 2 , Pages 208-211 , April 2007

Article Tools